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Abstract
Background: The Leapfrog Group recommended that coronary artery bypass grafting (CABG) surgery
should be done at high volume hospitals (>450 per year) without corresponding surgeon-volume criteria.
The latter confounds procedure-volume effects substantially, and it is suggested that high surgeon-volume
(>125 per year) rather than hospital-volume may be a more appropriate indicator of CABG quality.
Methods: We assessed 3-year isolated CABG morbidity and mortality outcomes at a low-volume hospital
(LVH:  504 cases) and compared them to the corresponding Society of Thoracic Surgeons (STS) national
data over the same period (2001–2003). All CABGs were performed by 5 high-volume surgeons (161–285
per year). "Best practice" care at LVH – including effective practice guidelines, protocols, data acquisition
capabilities, case review process, dedicated facilities and support personnel – were closely modeled after
a high-volume hospital served by the same surgeon-team.
Results: Operative mortality was similar for LVH and STS (OM: 2.38% vs. 2.53%), and the corresponding
LVH observed-to-expected mortality (O/E = 0.81) indicated good quality relative to the STS risk model
(O/E<1). Also, these results were consistent irrespective of risk category: O/E was 0, 0.9 and 1.03 for very-
low risk (<1%), low risk (1–3%) and moderate-to-high risk category (>3%), respectively. Postoperative leg
wound infections, ventilator hours, renal dysfunction (no dialysis), and atrial fibrillation were higher for
LVH, but hospital stay was not. The unadjusted Kaplan-Meier survival for the LVH cohort was 96%, 94%,
and 92% at one, two, and three years, respectively.
Conclusion: Our results demonstrated that high quality CABG care can be achieved at LVH programs if
1) served by high volume surgeons and 2) patient care procedures similar to those of large programs are
implemented. This approach may prove a useful paradigm to ensure high quality CABG care and early
efficacy at low volume institutions that wish to comply with the Leapfrog standards.
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Background
For many years investigators have studied the relationship
between the outcomes of high procedure-volume institu-
tions with those of low procedure-volume institutions.
This has been especially true for coronary artery bypass
grafting (CABG) surgery with varied results [1-11].
Indeed, recent studies have indicated that low volume-
procedure institutions performing CABG surgery may
have good outcomes particularly if associated with high
volume surgeons (> 125 cases per year) [12-15].
In this report we review our experience with a recently ini-
tiated small community hospital cardiac surgery program
modeled after a similar high volume practice in the
region. In this paradigm a group of high volume cardiac
surgeons expanded their practice, protocols, and proce-
dures to include the smaller institution. We reasoned that
this paradigm can be used successfully by low volume
hospitals. We tested this contention by comparing the
operative and midterm results of an LVH to the national
data as reported for the Society of Thoracic Surgeons (STS)
National Cardiac Database over the same period.
Methods
Patients
We retrospectively reviewed the initial 504 patients of a
new cardiac surgery program undergoing isolated CABG
between February 1, 2001 – December 31, 2003 at Saint
Luke's Hospital (Maumee, Ohio), a 189-bed community
hospital in Northwest Ohio. The information was
extracted from a local database. Patients were excluded if
they had concomitant valve, other cardiac, or carotid sur-
gery. Institutional Review Board approval was obtained
for this ongoing clinical cardiac surgery database research.
The requirement for informed consent was waived by the
Institutional Review Board.
Clinical data / end points
Clinical data on patients undergoing revascularization
have been systematically abstracted and recorded in a
dedicated cardiac surgery database, and are regularly
reported to the STS national cardiac surgery database. The
primary end points were operative mortality and morbid-
ity (complications and length of hospital stay), and those
were compared to the STS 2001–2003 data. In addition,
LVH 0- to 3-year all-cause mortality for survival data was
collected and combined via the Social Security Death
Index (conducted in August 2004). Allowing for a 3-
month lag, this corresponds to a follow-up between 5 and
41 months.
Statistical analysis
Continuous data were expressed as mean ± SD. Baseline
variables were compared by use of the Wilcoxon rank-sum
test, t-test, or the χ 2  test as appropriate. Actual, risk-
adjusted and observer-to-expected operative mortality
(OM, Adj. OM, and O/E, respectively) data are reported as
per the latest STS CABG risk model [16]. Effects of explan-
atory variables on OM were derived by logistic regression.
Survival was compared with Kaplan-Meier analysis (log
rank test) and multivariable Cox proportional-hazards
regression. The latter was done to assess the effects of the
varying death hazard on long-term mortality predictors
and their associated risk ratios (RR). Regression model
selection was done with backward elimination (Wald sta-
tistic – confirmed using forward and stepwise selection).
A P < 0.05 cutoff was used to indicate significance (SPSS
version 10.0, SPSS Inc., Chicago, IL).
Results
A total of 504 CABG procedures were performed in the
initial 35 months of this new cardiac surgery program.
This LVH population demonstrated a similar distribution
of age and gender to that of the STS, whereas race and
body mass index differed significantly (Table 1). Our LVH
patients had a higher incidence of three vessel disease,
obesity, preoperative myocardial infarction and family
history of coronary artery disease. The STS cohort exhib-
ited more peripheral vascular disease, chronic obstructive
pulmonary disease, angina, preoperative renal failure,
hypercholesterolemia, congestive heart failure, and
trended toward more cerebral vascular accidents (p = .06).
These differences in preoperative morbidity led to a lower
STS predicted mortality risk in our population, 2.94% vs.
3.13%. The LVH cohort had a relatively greater incidence
of emergencies, use of internal mammary arteries, use of
intra-aortic balloon pumps, and blood transfusions. The
incidence of elective cases, redo surgery, and off-pump
procedures were less than the STS. Total CPB (cardiopul-
monary bypass) and cross-clamp times were shorter.
Our LVH operative mortality (OM) did not statistically
differ from the STS (2.38% vs. 2.53%). The corresponding
O/E morality ratio was 0.81 and adjusted OM was 1.9%.
Multivariate OM predictors were age, emergency status,
and time on cardiopulmonary bypass (Table 2). The
patients in the very low risk (<1%) and low risk (1–3%)
categories fared better than the STS with actual mortality
rates and O/E mortality ratios of 0%, 0.0 and 0.9%, 0.52,
respectively. The moderate to high-risk category (>3%)
had an actual mortality rate (7.3%) and an O/E mortality
ratio (1.03) that were comparable to the STS.
Compared to the STS data, post-operative complications
of leg wound infection, prolonged ventilation, renal dys-
function (no dialysis), and atrial fibrillation occurred
more frequently at our LVH (Table 3). Also, LVH had a
greater rate of 30-day readmissions. However, total length
of stay, post-operative length of stay, post-operativeBMC Surgery 2005, 5:10 http://www.biomedcentral.com/1471-2482/5/10
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ventilator hours, strokes, sepsis, pneumonia, urinary tract
infection, and sternal wound infection were similar.
Unadjusted Kaplan-Meier survival was 96%, 94 %, and
92% at 1, 2, and 3 years, respectively (Figure 1), which was
comparable to the STS. Effects of six patient variables on
survival are shown in Figure 2. Gender and diabetes did
not affect midterm survival, while survival for older (> 65
years) patients, cerebral vascular disease, longer time on
CPB, and higher STS predicted operative mortality risk all
exhibited significantly worse midterm survival.
Predictors of 0–3 year mortality were derived by multivar-
iate (proportional hazard) Cox regression analysis and
included longer time on CPB (RR = 1.15), all vein grafts
(RR = 5.74), cerebral vascular disease (RR = 3.79), age (RR
Table 1: Patient Demographics, Risk Factors and Operative Data
Variable Study Site n mean ± SD 2001–2003 % median 
(25%–75%)
STS (2001–03) % median 
(25%–75%)
P-Value
No. of Patients 504 448841
Demographics/Risk Factors
Age (yrs) 64 ± 11 65 (56–72) 66 (57–74)
Male 368 73.0 71.3 .433
Caucasian 474 94.0 87.1 <.001
Black 5 1 5.17 <.001
Hispanic/Other 25 4.96 6.84
BSA (m2) 2.08 ± 0.25 2.08 (1.89–2.26) 1.95 (1.82 – 2.13) <.001
Obese (BMI>35 kg/m2) 103 20.4 13.4 <.001
Current Smoker 101 20 22.1 .295
Family History of CAD 403 80 43.2 <.001
Diabetes 168 33.30 35.0 .469
Insulin-dependent 41 8.13 10.47 .102
Hypercholesterolemia 323 64 68.49 .038
Renal Failure 10 1.98 5.20 .002
Hypertension 358 71 74.78 .060
Peripheral Vascular Disease 35 6.94 15.80 <.001
Cerebrovascular Disease 60 11.90 13.21 .425
COPD 68 13.50 18.61 .004
Myocardial Infarction 266 52.80 45.53 <.001
Congestive Heart Failure 44 8.73 13.80 <.001
Unstable 222 44.10 47.05 .193
Arrhythmia (any) 42 8.30 9.43 .443
Triple Vessel Disease 422 83.70 74.63 <.001
Left Main Disease >50% 118 23.40 24.54 .594
Ejection Fraction (%) 48 ± 11 50 (40–55) 50 (40–60)
Previous CV intervention 116 23.00 20.36 .155
Operative Data
Elective 129 25.60 51.88 <.001
Emergent 63 12.50 4.10 <.001
Redo Surgery 15 2.98 8.93 <.001
No. of Grafts 3.58 ± 1.01
Arterial 1.63 ± 0.98
Vein 1.94 ± 0.98
ITA Used 473 93.80 89.84 .004
Left ITA used 471 93.50 89.34 .004
Aortic Cross-Clamp (min) 58 ± 22 55 (45–68) 63 (47 – 83) .004
Perfusion time (min) 90 ± 31 85 (70–106) 94 (73 – 119)
Off-pump 21 4.17 20.48 <.001
STS Predicted Mortality (%) 2.94 ± 5.0 3.13
Ejection fraction was available in 464 patients. CV intervention = any cardiovascular intervention (surgery, angioplasty, or stenting). The urgent 
cases (197/504) are not compared in the STS database.BMC Surgery 2005, 5:10 http://www.biomedcentral.com/1471-2482/5/10
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= 1.63 per 10 years), redo surgery (RR = 3.46), and conges-
tive heart failure (RR = 2.48). Preoperative renal failure
approached significance (RR = 3.81, p = .078) (Table 4).
Discussion
While many researchers have found hospitals with higher
CABG volumes to be associated with better outcomes,
there has been significant interest in the potentially con-
founding influence of cardiothoracic surgeon procedure-
volumes on this association [1,2,5,11,13-17]. Four states
(California, New York, New Jersey, and Pennsylvania),
which represent a quarter of the US population, have rig-
orous reporting systems for CABG procedures based on
risk-adjusted mortality alone. In these states the Leapfrog
standard includes only those hospitals in the top quartile.
These "top" hospitals had overall mortality rates of 1.7%
compared with 4.1% in the lower quartiles. In the rest of
the nation, volume (>450 cases per annum) and mortality
rates below 2.7% comprise the Leapfrog standard [18].
The use of standard risk-adjusted mortality rates may
become the benchmark if rigorous outcomes measure-
ment systems are implemented throughout the United
States. Risk adjustment makes surgeon procedure volume
very important. In this way, certain cases may be restricted
to particular procedure volume surgeons, thus patient
redistribution to regional centers may not be necessary.
Three recent studies of note have highlighted the critical
importance of surgeon procedure volume [13-15]. Peter-
son et al found that hospital procedure-volume, as a qual-
ity marker in CABG surgery, was to be only modestly
associated with risk-adjusted CABG mortality rates [14].
In fact, these researchers clearly identified many low-vol-
ume hospitals with low mortality rates and several high
Table 2: Multivariate predictors of operative mortality by logistic regression applied to 504 patients
95%C.I.
Variables B S.E. Wald Sig. OR Lower Upper
Age (yr) .092 .035 6.942 .008 1.096 1.024 1.173
Emergency 1.312 .674 3.788 .052 3.712 .991 13.908
Time on CPB (min) .026 .007 13.421 .000 1.027 1.012 1.041
Constant -12.977 2.788 21.673 .000 .000
Table 3: Operative Outcomes
Variable Study Site n mean (SD) 2001–03 % median (25%–75%) STS (2001–03) % median (25%–75%) P – value
Intra-aortic Balloon pump (any) 73 14.5 9.2 <.001
Blood Transfusion (Any) 256 50.8 45.3 .014
Complication
ReOp Bleeding 14 2.78 2.50 .798
Perioperative myocardial infarction 3 0.60 1.07 .414
Sternal wound infection 1 0.20 0.47 .578
Leg wound infection 14 2.78 0.70 <.001
Septicemia 7 1.39 1.03 .570
Urinary Infection 9 1.79 1.67 .973
Permanent Stroke 4 0.79 1.53 .242
Transient Stroke 7 1.39 0.93 .406
Post-Op Ventilator (hours) 23.2 80.3 6.3 (4.0–15.8) 21.73
Ventilator Prolonged (>24 hrs) 53 10.5 7.5 .012
Pneumonia 15 2.98 2.87 .989
Renal Failure 34 6.75 3.47 <.001
Atrial Fibrillation 144 28.6 19.9 <.001
Operative Mortality 12 2.38 2.53 .940
Total LOS (days) 8.59 6.11 7 (5–10) 8.97
Post-Op LOS (days) 6.45 5.27 5 (4–7) 6.87
30-day Readmission 59 11.7 8.4 .009BMC Surgery 2005, 5:10 http://www.biomedcentral.com/1471-2482/5/10
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volume centers with higher than expected rates. In addi-
tion, Wu et al indicated that high volume cardiothoracic
surgeons were associated with a lower risk of death for
both low-risk and moderate-to-high risk CABG patients
[15] and Birkmeyer et al demonstrated that the observed
associations between hospital volume and operative mor-
tality were modulated by surgeon volume [13].
The establishment of the STS National Cardiac Database
has facilitated quality of care comparisons of cardiac sur-
gery programs relative to national statistics [19-21]. The
Center for Medicare and Medicaid Services (CMS) and the
Leapfrog group have suggested that hospital volume be
used as the indicator of the quality of CABG outcomes
[22-24]. However, an insightful review of the evidence by
Shahian and Normand lends merit to the argument that
CABG surgery is so pervasive that its well-recognized tech-
niques and well-understood pathophysiology make pro-
vision for its transportability to low volume institutions in
the hands of skilled, high volume surgeons [25]. The
recent Peterson et al investigation of the STS database
accounted for clinical factors, differences in site variability
and clustering within sites. They documented that (1) low
volume institutions tended to operate more often on
patients under emergent conditions, (2) the association
between hospital volume and mortality was different for
younger (<65 years) vs. older (>65 years) patients, (3) the
hospital volume and outcome associations were con-
founded by the concomitant effect of surgeon volume,
and (4) hospital volume per se was a poor predictor of
CABG outcome [14].
In view of the above studies the issue of volume as a
"proxy" yields itself to discussion. Some have criticized
hospital volume as a crude indicator of surgical quality in
that hospital volume is only a proxy for low mortality
(high quality) [26-29]. Volume must be examined from
the perspective of, not only the hospital, but also of the
surgeon. The procedure volume of surgeons is an impor-
tant proxy for quality CABG care. In this light, our exam-
ple of a high quality, low volume center should not be
unexpected, especially when our LVH used high volume
surgeons.
Our study site was a small, low procedure volume hospital
located in an increasingly affluent suburban community
with a large rural catchment area. This accounted for the
large number of Caucasians and the under-representation
of African-Americans. The increased body surface area and
excessive obesity that occurred in our population was to
be expected according to findings that indicate Ohio is
near the leading edge of the obesity experience in the
United States [30,31]. The study site patients had more
significant family histories of coronary artery disease
(CAD), but we cannot comment as to the extent of the
effect of genetic predisposition versus social impact (over-
eating, smoking, lack of exercise) had upon this finding.
However, the extent of obesity, and family histories of
CAD could account for the significant deviation from the
STS in regard to triple vessel disease and history of myo-
cardial infarction.
The relatively recent initiation of this cardiac surgery pro-
gram and its rural catchment area may account for the dis-
tribution of cases (fewer elective and redo surgeries, but
more emergent cases) because: (1) the cardiac surgery
program was actually put into place to support interven-
tional cardiology, (2) the cadre of cardiologists was not as
well established at this location and had fewer elective
cases posted, (3) the proximity to several rural hospitals
allowed rural emergent cases (whether initially presenting
to the study site emergently or becoming emergent during
their rural hospital stay) to receive expeditious care, (4)
the surgeons did not have an office in the immediate area
and this affected their contribution of elective cases to the
institution, and (5) a newly established program would
have less opportunity to perform redo surgeries.
The surgeons at the study location were very experienced
and were strong advocates of mammary and radial artery
use [32], and this is reflected in their shorter aortic cross-
clamp (perfusion) times and their use of internal mam-
mary grafts as compared to the STS. However, the surgical
group was less enthusiastic for the use of off-pump coro-
nary artery bypass procedures. The increased use of intra-
aortic balloon pumps and blood transfusions in our pop-
ulation may be attributed to the increased severity of
Kaplin-Meyer survival curve for 504 LVH CABG patients Figure 1
Kaplin-Meyer survival curve for 504 LVH CABG patients. 
Bars = standard error.
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Effects of gender, age, diabetes, cerebrovascular disease, time on CPB, and operative mortality (OM) on midterm survival Figure 2
Effects of gender, age, diabetes, cerebrovascular disease, time on CPB, and operative mortality (OM) on midterm survival. P 
value reflects log-rank test results.
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illness as represented by an increased percentage of
emergent cases, preoperative myocardial infarctions, and
triple vessel disease.
The postoperative complications of renal dysfunction (no
dialysis), prolonged ventilation greater than 24 hours, leg
wound infection, atrial fibrillation, and 30-day readmis-
sion deviated from the STS. Postoperative renal dysfunc-
tion was not associated with an increased need for
dialysis. The higher rate of renal dysfunction may be
linked to a higher incidence of emergent cases done soon
after cardiac catheterization. Such prompt surgeon
response may not allow sufficient time for elimination of
the contrast dye that may exacerbate the associated neph-
ropathy [33].
Postoperative atrial fibrillation in our population is
greater than the STS, but is within the range reported by
others [34,35]. This may be related to the greater inci-
dence of emergent cases and shorter catheterization-to-
surgery times. The latter may have compromised the effi-
cacy our implementation of the amiodarone prophylaxis
protocol in high-risk atrial fibrillation patients.
The prolonged rate of postoperative ventilation may be a
function of anesthesiology practice. In the evening the car-
diothoracic anesthesiologist covers the intensive care unit
by beeper. Although protocols are in place regarding extu-
bation and the anesthesiologist can be consulted at any
hour, we have found that there is reluctance to extubate
patients between midnight and 0600 on the part of the
staff. However, this did not influence the length of stay or
the rate of pneumonia.
The cardiovascular surgical assistants hired at the study
location initially had limited experience with the surgical
care of leg wounds. Their ability to care intra-operatively
and post-operatively for leg wounds has improved and is
under a continuous quality improvement process. The
extent of obesity and emergent cases in our population
may be a contributing factors to poor wound healing.
Also, the emergent cases arrive in the operating room on
many occasions after administration of antiplatelet drugs
and this may contribute to postoperative hematoma for-
mation and infection at the leg wound sites.
An increased 30-day readmission rate of the study site was
also noted. The surgeons initiating this cardiac surgery
program had heightened awareness as to potential patient
complications in a "new" program and did not hesitate to
readmit a patient of questionable physiologic status.
In our paradigm a group of high volume surgeons from a
high volume hospital (HVH) established a new LVH car-
diothoracic surgery program providing practice guide-
lines, protocols and data acquisition capabilities. In
addition, the physical layout of the cardiac surgery wing
and the organization of the cardiovascular intensive care
unit (CVU) within a dedicated heart center were of
paramount importance. It included two cardiac catheteri-
zation suites with a 10 bed holding area, two operating
suites were immediately adjacent to an eight-bed CVU
used as intensive care, step-down and floor beds if capac-
ity permitted ("one-stop" for all patients). An experienced
critical care nursing staff was recruited from the HVH. In
addition, two anesthesiologists/intensivists with trans-
esophageal echocardiography skills were dedicated exclu-
sively to the heart center. They were responsible for the
pre-, intra-, and postoperative critical care of all the
patients. The CVU model was one that involved the car-
diac surgeon as the primary physician; however the
anesthesiologists were consulted on every case to support
the global care given to the patient. This was particularly
beneficial to the surgeons because their practice involved
three institutions in addition to their office practice. Also,
daily group rounds included a surgeon, anesthesiologist,
Table 4: Predictors of 0 – 3 year mortality derived by Multivariate (proportional hazard) Cox regression analysis.
Variables B SE Wald Risk Ratio P-value 95% C.I.
Time on CPB (per 10 minutes) 0.02 0.00 16.26 0.0001 1.15 1.08 1.23
All vein grafts 1.75 0.55 10.15 0.0014 5.74 1.96 16.82
Cerebrovascular Disease 1.33 0.43 9.82 0.0017 3.79 1.65 8.72
Age (per 10 years) 0.06 0.02 8.28 0.0040 1.63 1.20 1.91
Redo Surgery 1.24 0.55 5.00 0.0254 3.46 1.17 10.26
Congestive Heart Failure 0.91 0.45 4.07 0.0435 2.48 1.03 6.00
Pre-operative Renal Failure 1.34 0.76 3.11 0.0779 3.81 0.86 16.86
95% C.I = 95% confidence interval; CPB = cardiopulmonary bypass;
Predictors are arranged by decreasing Wald statisticBMC Surgery 2005, 5:10 http://www.biomedcentral.com/1471-2482/5/10
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nurse, respiratory therapist, and pharmacist. Each month
a meeting was held, not only for case review, but to assess
the program's performance against the STS database.
Clearly, surgeon procedure-volume examination will
cause controversy [36-38], but studies of risk-adjusted
data indicate that surgeon volume is of significant impor-
tance [13,14,16,17]. In the setting of a LVH where there
are more emergent and high risk patients [14] there
should be a continuous quality improvement effort in
place to ensure "best practice", evidence-based care is
offered to patients [12].
Conclusion
We demonstrated that high quality CABG care with good
outcomes can be achieved at a LVH program provided
that that it is served by high volume cardiac surgeons and
backed up by a highly trained, dedicated support team,
and a sophisticated data acquisition capability and review
process. This approach may prove a useful paradigm to
ensure high quality CABG care and early efficacy at low
volume institutions that wish to be compliant with Leap-
frog recommendations.
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